Research Advances in the Mechanisms of Gastric Cancer Multidrug Resistance
Overview
Authors
Affiliations
Gastric cancer is one of the most common human malignancies and the third cause of death from cancer in China and worldwide. Chemotherapy is still one of the major treatment options for advanced gastric cancer. However,the efficacy of chemotherapy for gastric cancer remains poor due to its insensitivity and the development of multidrug resistance (MDR). While many molecules and mechanisms have been found to be associated with the development of gastric cancer MDR,the specific mechanisms remains unclear. In our current article,we reviews the identification of MDR-related molecules and mechanisms,with an attempt to a better understand the specific mechanisms of gastric cancer MDR and thus provide new insights into the fight against gastric cancer MDR.
Su G, Wang J, Liu S, Fu X, Li Y, Pan G Int J Gen Med. 2025; 17:6567-6584.
PMID: 39759895 PMC: 11697670. DOI: 10.2147/IJGM.S496006.
Ghrelin Affects Gastric Cancer Progression by Activating AMPK Signaling Pathway.
Hu X, Zhu Y, Hu C, You L, Wu J, He X Biochem Genet. 2021; 59(3):652-667.
PMID: 33442814 DOI: 10.1007/s10528-020-10022-x.
Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents.
Huang W, Ruan S, Wen F, Lu X, Gu S, Chen X Cancer Manag Res. 2020; 12:12385-12394.
PMID: 33293864 PMC: 7719322. DOI: 10.2147/CMAR.S274599.
Huang W, Tang H, Wen F, Lu X, Li Q, Shu P BMC Complement Med Ther. 2020; 20(1):196.
PMID: 32586310 PMC: 7318551. DOI: 10.1186/s12906-020-02983-8.
A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.
Ruan T, Liu W, Tao K, Wu C Onco Targets Ther. 2020; 13:1797-1807.
PMID: 32184615 PMC: 7053652. DOI: 10.2147/OTT.S239336.